In line with our findings, the overactivation of CCL5-CCR5 signaling and their oncogenic effects on tumor malignant behaviors have been reported in other cancers.28,40,41 These results underlie the importance of targeting the CCL5-CCR5 axis for tumor treatment. The gene discussed is CCL5; the disease is neoplasm.